Musk may soften Terafab control stance in fresh TSMC talks - Proactive financial news

Musk's softening on Terafab control is not capitulation—it's a repricing of "control for capacity." The AI compute bottleneck has migrated from architecture to advanced-node yield and CoWoS packaging, with allocation queues stretching past H2 2026. Insisting on excessive process constraints over TSMC trades an illusion of control for N2 capacity he cannot secure elsewhere. The technical ripple is structural: if TSMC retains greater PDK sovereignty, custom AI accelerator back-end design must conform to its DRC rules. Tesla's AI5/AI6 and xAI inference silicon lose meaningful transistor-density headroom—but gain certainty in a window where Intel IFS yield remains volatile and Samsung's 2nm trails a generation. On compliance, if Terafab is US-sited, TSMC retaining process IP actually reduces CFIUS exposure by avoiding the "foreign technology transfer" classification. That is a cost reduction for both parties, not a concession. Competitively, NVIDIA and AMD will track the capacity lock-in scale. If Musk trades control for priority allocation at TSMC's Arizona fab beyond 2026, he builds a de facto capacity moat in HBM plus advanced packaging that rivals cannot replicate. 12-24 month thesis: the industry is shifting from the binary "IDM vs. Foundry" narrative to "AI-native vertical integration"—designers embed deeply in process development without owning fabs. Terafab will be the first stress test of this paradigm.